• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼征联合脑脊液白细胞介素-6 对神经精神狼疮的诊断价值。

Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.

机构信息

Department of Therapeutics & Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

Li Ka Shing Institute of Health Science (LiHS), The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

出版信息

Int J Rheum Dis. 2023 Aug;26(8):1464-1473. doi: 10.1111/1756-185X.14731. Epub 2023 Jun 27.

DOI:10.1111/1756-185X.14731
PMID:37366596
Abstract

OBJECTIVES

To ascertain whether microvascular alterations of eye sign combined with intrathecal concentrations of interleukin-6 (IL-6) can predict the development of neuropsychiatric systemic lupus erythematosus (NPSLE).

METHODS

Cerebrospinal fluid (CSF) and serum samples of IL-6 were collected and measured at the same time for patients with SLE who were consecutively enrolled. Patients with a diagnosis of NPSLE were identified. Eye sign examinations according to our criteria were performed and scored for all SLE patients. Demographic and clinical parameters were compared between groups to identify potential predictors for NPSLE using multivariable logistic regression analysis. The performance of potential predictors from eye sign along with IL-6 in the CSF was assessed.

RESULTS

A total of 120 patients with SLE were enrolled; 30 with NPSLE and 90 with non-NPSLE. No significant positive correlation was observed between CSF level and serum level of IL-6. CSF IL-6 was significant higher in the NPSLE group than the non-NPSLE (P < 0.001) group. Multivariable logistic analysis revealed that total score, ramified loops, and microangioma of eye sign were predictors for NPSLE after adjusting for SLE Disease Activity Index (SLEDAI) and antiphospholipid antibody (APL). Total score, ramified loops, microangioma of eye sign, and SLEDAI remain significant predictors for NPSLE after adjusting for CSF IL-6. Using receiver operating characteristics curve analysis, the cut-off point of potential predictors was applied in multivariable logistic analysis; APL, total score, ramified loops, and microangioma of eye sign remain significant predictors for NPSLE after adjusting for CSF IL-6.

CONCLUSION

Specific microvascular alterations of eye sign are predictors for the development of NPSLE in addition to increased IL-6 in the CSF.

摘要

目的

确定眼部微血管改变与鞘内白细胞介素-6(IL-6)浓度是否可预测神经精神性系统性红斑狼疮(NPSLE)的发生。

方法

连续招募系统性红斑狼疮(SLE)患者,同时采集脑脊液(CSF)和血清样本以测量 IL-6。确定 NPSLE 患者。对所有 SLE 患者进行了根据我们的标准进行的眼部检查并进行评分。使用多变量逻辑回归分析比较组间的人口统计学和临床参数,以确定 NPSLE 的潜在预测因素。评估来自眼部特征以及 CSF 中 IL-6 的潜在预测因素的性能。

结果

共纳入 120 例 SLE 患者,其中 30 例为 NPSLE,90 例为非 NPSLE。CSF 中 IL-6 水平与血清水平之间未观察到显著正相关。NPSLE 组的 CSF IL-6 明显高于非 NPSLE 组(P < 0.001)。多变量逻辑分析显示,在调整 SLE 疾病活动指数(SLEDAI)和抗磷脂抗体(APL)后,眼部特征的总评分、分支环和微血管瘤是 NPSLE 的预测因素。在调整 CSF IL-6 后,总评分、分支环、微血管瘤和 SLEDAI 仍然是 NPSLE 的重要预测因素。使用受试者工作特征曲线分析,潜在预测因素的临界点应用于多变量逻辑分析;在调整 CSF IL-6 后,APL、总评分、分支环和微血管瘤仍然是 NPSLE 的重要预测因素。

结论

除 CSF 中 IL-6 增加外,眼部特定的微血管改变也是 NPSLE 发生的预测因素。

相似文献

1
Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.眼征联合脑脊液白细胞介素-6 对神经精神狼疮的诊断价值。
Int J Rheum Dis. 2023 Aug;26(8):1464-1473. doi: 10.1111/1756-185X.14731. Epub 2023 Jun 27.
2
IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.在中枢神经精神性狼疮患者的脑脊液中,白细胞介素-6、白细胞介素-8、干扰素γ诱导蛋白10、单核细胞趋化蛋白-1和粒细胞集落刺激因子显著升高,但在血清中未升高。
Lupus. 2016 Aug;25(9):997-1003. doi: 10.1177/0961203316629556. Epub 2016 Feb 3.
3
The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.神经精神性系统性红斑狼疮的异质性体现在其与脑脊液细胞因子谱缺乏相关性。
Lupus. 2003;12(11):846-50. doi: 10.1191/0961203303lu472sr.
4
A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.神经精神性狼疮的血清和脑脊液自身抗体的荟萃分析。
Autoimmun Rev. 2016 Feb;15(2):124-38. doi: 10.1016/j.autrev.2015.10.003. Epub 2015 Oct 23.
5
Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.神经精神性系统性红斑狼疮患者脑脊液白细胞介素-6的临床分析
Fukuoka Igaku Zasshi. 2010 Feb;101(2):34-40.
6
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.神经精神性系统性红斑狼疮患者的补体水平及抗C1q自身抗体
Lupus. 2016 Jul;25(8):878-88. doi: 10.1177/0961203316643170.
7
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.神经精神性系统性红斑狼疮患者脑脊液中纤溶酶原激活物抑制剂1水平升高与神经元破坏之间的关系
Arthritis Rheum. 2009 Jul;60(7):2094-101. doi: 10.1002/art.24603.
8
The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus.狼疮特异性自身抗体和白细胞介素-6在系统性红斑狼疮脑干和脊髓脱髓鞘中的致病作用。
Lupus. 2023 Mar;32(3):401-410. doi: 10.1177/09612033231151600. Epub 2023 Jan 11.
9
Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.神经精神性狼疮伴发癫痫患者血清游离白细胞介素-18 升高。
Lupus. 2022 Feb;31(2):187-193. doi: 10.1177/09612033211069853. Epub 2022 Jan 19.
10
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.系统性红斑狼疮患者鞘内APRIL和BAFF水平升高:与神经精神症状的关系
Arthritis Res Ther. 2008;10(4):R97. doi: 10.1186/ar2484. Epub 2008 Aug 22.

引用本文的文献

1
Prediction model for developing neuropsychiatric systemic lupus erythematosus in lupus patients.狼疮患者发生神经精神性系统性红斑狼疮的预测模型。
Clin Rheumatol. 2024 Jun;43(6):1881-1896. doi: 10.1007/s10067-024-06970-z. Epub 2024 Apr 27.